构建冠心病心绞痛中医病证结合疗效评价量表体系的构想

发布时间：2018-01-11 05:18

本文关键词：构建冠心病心绞痛中医病证结合疗效评价量表体系的构想　出处：《中华中医药学刊》2017年08期 　论文类型：期刊论文

【摘要】：以量表为载体的生存质量已被引入中医药行业中,用于中医药临床疗效评价。但现有量表存在诸多不足,不能凸显中医特色优势。国内外学者开展探讨研制符合中医疗效评价的量表。通过回顾国内外中医量表的研究现状,发现无论是疾病特异性量表还是证候特异性量表,均存在不足之处。在前期通过改良西雅图心绞痛量表(SAQ),在其基础上加入中医痰瘀互结证候维度,建立了冠心病心绞痛中医病证结合评价量表(TCMSAQ),经临床应用,信度、效度、反应度良好。中医临床证候复杂多样,无法逐一研制相关病证量表。借鉴美国西北大学慢性病评价量表的研制方法,引入共性模块、特异性模块相结合的方法,在现有西雅图心绞痛量表(SAQ)的基础上,加入中医普适性症状,研制"冠心病心绞痛中医病证结合疗效评价量表共性模块(TCM-SAQ-GM)",并针对冠心病心绞痛常见中医基本证型,如气虚、痰浊、瘀血等,研制"证候特异性模块(TCM-SAQ-SM)",将TCM-SAQ-GM与TCM-SAQ-SM组合,构建冠心病心绞痛中医病证结合疗效评价量表体系。
[Abstract]:The quality of life with the scale as the carrier has been introduced into the traditional Chinese medicine industry to evaluate the clinical efficacy of traditional Chinese medicine, but there are many shortcomings in the existing scale. Can not highlight the advantages of traditional Chinese medicine. Domestic and foreign scholars to explore the development of a scale in line with the evaluation of TCM efficacy. By reviewing the domestic and foreign TCM scale research status. It was found that both the disease specificity scale and the syndrome specificity scale had shortcomings. In the early stage, the modified Seattle angina pectoris scale was used to add the syndromes dimension of phlegm and blood stasis in traditional Chinese medicine. The TCMSAQ scale was established for evaluating the combination of TCM and syndromes in angina pectoris of coronary heart disease. The clinical application showed that the reliability validity and reaction degree of TCM were good and the clinical syndromes of TCM were complex and varied. It is impossible to develop the relevant disease syndrome scale one by one. The method of combining the common module and the specific module is introduced for reference to the development method of the chronic disease evaluation scale of Northwestern University of the United States. On the basis of the existing Seattle angina pectoris scale (SSAQ), the general symptoms of TCM were added to develop the "Common Module of TCM Disease Syndrome and Therapeutic Evaluation scale for Coronary Heart Disease angina Pectoris combined with Disease Syndrome" (TCM-SAQ-GM). Aiming at the common TCM syndromes of angina pectoris of coronary heart disease, such as qi deficiency, phlegm turbidity, blood stasis and so on, the "syndrome specificity module TCM-SAQ-SM" was developed. The combination of TCM-SAQ-GM and TCM-SAQ-SM was used to construct the therapeutic effect evaluation scale system of angina pectoris combined with TCM disease and syndromes.
【作者单位】：辽宁中医药大学附属医院;辽宁中医药大学;
【基金】：国家自然科学基金青年科学基金项目(81503468)
【分类号】：R259
【正文快照】： 中医药临床疗效评价方法一直是影响中医药产业化、国际化进程的关键瓶颈问题。中医药的疗效评价应该符合中医理论特点和临床治疗宗旨,更应该选择有利于突显中医自身治疗特色与疗效优势的评价指标[1]。多年来,中药新药临床疗效的评价仍多借用西医的疗效评价标准,难以体现中医药

【相似文献】